The US Environmental Protection Agency (EPA) has alleged that Volkswagen Group of America (VW) violated the Clean Air Act (CAA) by developing and installing emissions control system 'defeat devices' (
The excise tax on high-cost health care plans, the so-called Cadillac tax, is good policy. Congress should side with President Obama and resist calls to scrap it.
Measuring consumer responsiveness to medical care prices is a central issue in health economics and a key ingredient in the optimal design and regulation of health insurance markets.
Not since the early, heady days of recombinant DNA (rDNA) has a technique of molecular biology so gripped the scientific imagination as the CRISPR-Cas9 method of gene editing.
The conventional wisdom in health economics is that idiosyncratic features of the healthcare sector leave little scope for market forces to allocate consumers to higher performance producers.
A combination of legal rules and institutional forces pushes health plans to cover nearly every medical innovation.
Two of the best known randomized trials in health economics are described in detail in this chapter, the RAND Health Insurance Experiment and the Oregon Health Insurance Experiment.
Prior analyses of Medicare health plans have examined either utilization of services or quality of care, but not both jointly.
In March 2015, the US Food and Drug Administration (FDA) approved the first biosimilar in the United States, ushering in the age of biosimilar competition for biologics.
In this article, the author responds to the articles within the issue that commented on his book "Bioethical Prescriptions." Topics discussed include the importance of certain types of temporal order
Get smart & reliable public policy insights right in your inbox.